These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1991108)

  • 1. Chemical modifications and amino acid substitutions in recombinant hirudin that increase hirudin-thrombin affinity.
    Winant RC; Lazar JB; Johnson PH
    Biochemistry; 1991 Feb; 30(5):1271-7. PubMed ID: 1991108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hirudin: amino-terminal residues play a major role in the interaction with thrombin.
    Lazar JB; Winant RC; Johnson PH
    J Biol Chem; 1991 Jan; 266(2):685-8. PubMed ID: 1985956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reevaluating the effects of tyrosine iodination of recombinant hirudin on its thrombin inhibition kinetics.
    Komatsu Y; Hayashi H
    Thromb Res; 1997 Aug; 87(4):343-52. PubMed ID: 9271811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probing the hirudin-thrombin interaction by incorporation of noncoded amino acids and molecular dynamics simulation.
    De Filippis V; Colombo G; Russo I; Spadari B; Fontana A
    Biochemistry; 2002 Nov; 41(46):13556-69. PubMed ID: 12427016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping of the thrombin des-ETW conformation by using site-directed mutants of hirudin. Evidence for the induction of nonlocal modifications by mutagenesis.
    Le Bonniec BF; Betz A; Guinto ER; Esmon CT; Stone SR
    Biochemistry; 1994 Apr; 33(13):3959-66. PubMed ID: 8142400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of hirudin to meizothrombin.
    Fischer BE; Schlokat U; Himmelspach M; Dorner F
    Protein Eng; 1998 Aug; 11(8):715-21. PubMed ID: 9749925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of hirudin with thrombin: identification of a minimal binding domain of hirudin that inhibits clotting activity.
    Mao SJ; Yates MT; Owen TJ; Krstenansky JL
    Biochemistry; 1988 Oct; 27(21):8170-3. PubMed ID: 3233202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversion of recombinant hirudin to the natural form by in vitro tyrosine sulfation. Differential substrate specificities of leech and bovine tyrosylprotein sulfotransferases.
    Niehrs C; Huttner WB; Carvallo D; Degryse E
    J Biol Chem; 1990 Jun; 265(16):9314-8. PubMed ID: 2345174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of regions of alpha-thrombin involved in its interaction with hirudin.
    Stone SR; Braun PJ; Hofsteenge J
    Biochemistry; 1987 Jul; 26(15):4617-24. PubMed ID: 3663613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrostatic steering and ionic tethering in the formation of thrombin-hirudin complexes: the role of the thrombin anion-binding exosite-I.
    Myles T; Le Bonniec BF; Betz A; Stone SR
    Biochemistry; 2001 Apr; 40(16):4972-9. PubMed ID: 11305913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in interactions in complexes of hirudin derivatives and human alpha-thrombin due to different crystal forms.
    Priestle JP; Rahuel J; Rink H; Tones M; Grütter MG
    Protein Sci; 1993 Oct; 2(10):1630-42. PubMed ID: 8251938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of heparin on the interaction between thrombin and hirudin.
    Stone SR; Hofsteenge J
    Eur J Biochem; 1987 Dec; 169(2):373-6. PubMed ID: 3691497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of hirudin-based inhibitor with thrombin: critical role of the IleH59 side chain of the inhibitor.
    Tsuda Y; Szewczuk Z; Wang J; Yue SY; Purisima E; Konishi Y
    Biochemistry; 1995 Jul; 34(27):8708-14. PubMed ID: 7612610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-function and refolding studies of the thrombin-specific inhibitor hirudin.
    Johnson PH; Sze P; Winant RC; Hudson D; Underhill P; Lazar JB; Olsen C; Almquist R
    Haemostasis; 1991; 21 Suppl 1():41-8. PubMed ID: 1894196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basis for the reduced affinity of beta T- and gamma T-thrombin for hirudin.
    Stone SR; Hofsteenge J
    Biochemistry; 1991 Apr; 30(16):3950-5. PubMed ID: 2018764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The structure of a complex of recombinant hirudin and human alpha-thrombin.
    Rydel TJ; Ravichandran KG; Tulinsky A; Bode W; Huber R; Roitsch C; Fenton JW
    Science; 1990 Jul; 249(4966):277-80. PubMed ID: 2374926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of hirudin with the dysthrombins Quick I and II.
    Stone SR; Schmitz T; Henriksen RA; Hofsteenge J; Dodt J
    Biochemistry; 1991 Jul; 30(26):6392-7. PubMed ID: 2054344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombin inhibition by hirudin: how hirudin inhibits thrombin.
    Fenton JW; Villanueva GB; Ofosu FA; Maraganore JM
    Haemostasis; 1991; 21 Suppl 1():27-31. PubMed ID: 1894193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of site specific hirudin variants with alpha-thrombin.
    Dodt J; Köhler S; Baici A
    FEBS Lett; 1988 Feb; 229(1):87-90. PubMed ID: 3345842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of fragments of hirudin to investigate thrombin-hirudin interaction.
    Dennis S; Wallace A; Hofsteenge J; Stone SR
    Eur J Biochem; 1990 Feb; 188(1):61-6. PubMed ID: 2180697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.